BioLife Solutions (BLFS) News Today

Isthmus Partners LLC lifted its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 34.4% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 165,247 shares of the medica

Raymond James & Associates acquired a new stake in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the second quarter, according to its most recent 13F filing with the SEC. The fund acquired 134,194 shares of the medical equipment provider's stock, valued at approximately $2,876,000. Ray

Lisanti Capital Growth LLC bought a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 74,877 shares of the medical equipment provider's stock, valued

Legato Capital Management LLC bought a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 10,877 shares of the medical equipmen

Calamos Advisors LLC purchased a new position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 57,250 shares of t

Shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been given a consensus recommendation of "Buy" by the five research firms that are currently covering the company, Marketbeat Ratings reports. Five equities research analysts have rated the stock with a buy recommendation. The

Sequoia Financial Advisors LLC acquired a new stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 21,730 shares of the medical equip

Craig Hallum upped their target price on shares of BioLife Solutions from $23.00 to $30.00 and gave the company a "buy" rating in a research note on Monday.

Northland Securities lifted their price objective on shares of BioLife Solutions from $26.00 to $28.00 and gave the stock an "outperform" rating in a research note on Friday.

BioLife Solutions (NASDAQ:BLFS) Reaches New 12-Month High at $25.22

Harbor Capital Advisors Inc. increased its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 311.5% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 40,028 shares of the medical equ

BioLife Solutions (NASDAQ:BLFS) Sets New 1-Year High at $24.48

Shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been assigned an average rating of "Buy" from the five analysts that are covering the firm, Marketbeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation. The average twelve-month price tar

BioLife Solutions (NASDAQ:BLFS) Sets New 12-Month High at $23.32

BioLife Solutions (NASDAQ:BLFS) Trading Up 6%

BNP Paribas Financial Markets increased its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 249.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 53,515 shares of the medical equipment

TD Cowen boosted their price target on shares of BioLife Solutions from $20.00 to $26.00 and gave the stock a "buy" rating in a research report on Wednesday.

BioLife Solutions (NASDAQ:BLFS) Sets New 12-Month High at $23.25

BioLife Solutions (NASDAQ:BLFS) Trading Down 5.1%

BioLife Solutions (NASDAQ:BLFS) Shares Down 2.5%

Allspring Global Investments Holdings LLC raised its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 161,879.0% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 131,203 shares of the medical equipment provider's stock after purchas

Shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) have been given an average rating of "Buy" by the five research firms that are currently covering the stock, Marketbeat Ratings reports. Five research analysts have rated the stock with a buy rating. The average 1 year price objecti

BioLife Solutions (NASDAQ:BLFS) Trading 4.9% Higher

BioLife Solutions (NASDAQ:BLFS) Stock Price Down 4.2%

Goldman Sachs Group Inc. lifted its holdings in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 1,038.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,401,899 shares of the medical equipment provider's stock after b

BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) CMO Todd Berard sold 10,000 shares of BioLife Solutions stock in a transaction dated Friday, June 14th. The stock was sold at an average price of $20.18, for a total value of $201,800.00. Following the sale, the chief marketing officer now owns 108,894 shares of the company's stock, valued at approximately $2,197,480.92. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Palisade Capital Management LP trimmed its position in BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 11.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,213,334 shares of the medical equipment provider's stock

BioLife Solutions (NASDAQ:BLFS) Trading Down 5.6%

Granahan Investment Management LLC raised its stake in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 22.8% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,292,675 shares of the medical equipment provider's stock after purchasing an addit

Stephens Inc. AR decreased its position in shares of BioLife Solutions, Inc. (NASDAQ:BLFS - Free Report) by 31.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 83,928 shares of the medical equipment provider's st

BioLife Solutions, Inc. (NASDAQ:BLFS - Get Free Report) has been given an average recommendation of "Buy" by the five ratings firms that are currently covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a buy rating. The average 12-month price targe